Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy

W. Christopher Ehmann; Robert Silber

doi:10.1016/0002-9343(86)90673-X

Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy

W. Christopher Ehmann
, Robert Silber

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

Splenectomy has been the traditional initial treatment for hairy cell leukemia, with medical treatment reserved for resistant disease. This report describes two patients treated with recombinant alpha-2 interferon without prior splenectomy. Both patients responded well to interferon therapy. Alpha-2 interferon may become the initial therapy of choice for hairy cell leukemia.

Original language	English (US)
Pages (from-to)	1111-1114
Number of pages	4
Journal	The American journal of medicine
Volume	80
Issue number	6
DOIs	https://doi.org/10.1016/0002-9343(86)90673-X
State	Published - Jun 1986

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.1016/0002-9343(86)90673-X

Cite this

@article{d8093e222aeb4041b510f2cad3b8df41,

title = "Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy",

abstract = "Splenectomy has been the traditional initial treatment for hairy cell leukemia, with medical treatment reserved for resistant disease. This report describes two patients treated with recombinant alpha-2 interferon without prior splenectomy. Both patients responded well to interferon therapy. Alpha-2 interferon may become the initial therapy of choice for hairy cell leukemia.",

author = "Ehmann, \{W. Christopher\} and Robert Silber",

note = "Funding Information: From the Division of Hematology, New York University Medical Center, New York, New York. This work was supported by Schering-Plough Protocol (X3-086-03. Requests for reprints should be addressed to Dr. Robert Silber, Division of Hematology, New York University Medical Center, 560 First Avenue, New York, New York 10016. Manuscript accepted February 11, 1986.",

year = "1986",

month = jun,

doi = "10.1016/0002-9343(86)90673-X",

language = "English (US)",

volume = "80",

pages = "1111--1114",

journal = "The American journal of medicine",

issn = "0002-9343",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy

AU - Ehmann, W. Christopher

AU - Silber, Robert

N1 - Funding Information: From the Division of Hematology, New York University Medical Center, New York, New York. This work was supported by Schering-Plough Protocol (X3-086-03. Requests for reprints should be addressed to Dr. Robert Silber, Division of Hematology, New York University Medical Center, 560 First Avenue, New York, New York 10016. Manuscript accepted February 11, 1986.

PY - 1986/6

Y1 - 1986/6

N2 - Splenectomy has been the traditional initial treatment for hairy cell leukemia, with medical treatment reserved for resistant disease. This report describes two patients treated with recombinant alpha-2 interferon without prior splenectomy. Both patients responded well to interferon therapy. Alpha-2 interferon may become the initial therapy of choice for hairy cell leukemia.

AB - Splenectomy has been the traditional initial treatment for hairy cell leukemia, with medical treatment reserved for resistant disease. This report describes two patients treated with recombinant alpha-2 interferon without prior splenectomy. Both patients responded well to interferon therapy. Alpha-2 interferon may become the initial therapy of choice for hairy cell leukemia.

UR - https://www.scopus.com/pages/publications/0022730286

UR - https://www.scopus.com/pages/publications/0022730286#tab=citedBy

U2 - 10.1016/0002-9343(86)90673-X

DO - 10.1016/0002-9343(86)90673-X

M3 - Article

C2 - 3728508

AN - SCOPUS:0022730286

SN - 0002-9343

VL - 80

SP - 1111

EP - 1114

JO - The American journal of medicine

JF - The American journal of medicine

IS - 6

ER -

Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this